Archives

A New Class of Drugs Is Pushing the Limits of Weight Loss

Medical weight loss might be on the verge of a further revolution. For starters, people will likely have the option of taking a new class of medications that seem to have fewer bothersome side effects, such as nausea—which affects about half the people on Ozempic and similar drugs. Those now-familiar medications target a pathway involving […]

Employers can expect +$18.5K in per-worker health insurance costs next year

Employers can anticipate a 6.7% increase in total health benefit costs in 2026 — the steepest in 15 years — according to the 2025 National Survey of Employer-Sponsored Health Plans from consulting firm Mercer. Mercer fielded responses from 2,010 employers for the study. What to know The cost per employee is slated to reach over […]

Ozempic and Mounjaro: ‘King Kong’ of Weight Loss or a Hammer Swinging at Your Health?

Rabat – Smoking kills, so do other diseases, other challenges, and other issues that we either underestimate or are truly unaware of the dangers they pose, including obesity. In response to gaining weight, many people resort to quick methods to shed some pounds, including those influenced by social media trends. Other methods also include injections. […]

The GLP-1 Era Is Changing How We Think About Self Control

Although scientists are just beginning to study food noise as a concept, individuals who have taken a GLP-1 drug often report that it significantly reduces this distracting, ruminative thinking about food – a near-constant background hum of unwanted food-related thoughts, feelings and desires that may contribute to making poor food choices. – Psyche

STAT+: Novo nears release of high-stakes data on Alzheimer’s and GLP-1s

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we report on how lawsuits linked to Covid-19 are gaining prominence under the Trump administration. We also await Novo results on GLP-1 effects on Alzheimer’s, and more. The need-to-know this morning Alkermes increased […]

BellRing Brands, Inc. (NYSE:BRBR) Q4 2025 Earnings Call Transcript

BellRing Brands, Inc. (NYSE:BRBR) Q4 2025 Earnings Call Transcript November 18, 2025 BellRing Brands, Inc. misses on earnings expectations. Reported EPS is $0.51 EPS, expectations were $0.546. Operator: Good day, and thank you for standing by. Welcome to the BellRing Brands Fourth Quarter Fiscal Year 2025 Earnings Conference Call. [Operator Instructions] Please be advised today’s […]

Parsing the Rhetoric on ACA Subsidies

In a social media post, Republican Sen. Ron Johnson criticized Sen. Bernie Sanders, an independent, for wrongly saying that Affordable Care Act premiums would at least double for “over 20 million Americans” if enhanced subsidies expire. They would more than double on average, not for all of those 20 million people. Johnson glossed over the […]

Jefferson health plan losses drag down Q1 performance

Philadelphia-based Thomas Jefferson University, owner of Jefferson Health, reported an operating loss of $103.8 million (-2.5% operating margin) in the first quarter of fiscal 2026, including $19.4 million in restructuring costs, according to its Nov. 14 financial report.  Restructuring costs for the three months ended Sept. 30 included employee severance and “other strategic actions to […]